Chemotherapy has been a standard part of breast cancer treatment for decades. It has helped countless patients survive the ...

A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...

No, Velcade isn’t a type of chemotherapy or immunotherapy drug. It is a type of targeted therapy used for certain types of blood cancer. It contains the active drug bortezomib, which belongs to a drug ...

The Prosigna genomic test may help identify breast cancer patients who are likely to gain little benefit from chemotherapy ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...

Urinary tract infections (UTIs) commonly occur in people who undergo chemotherapy. The treatment can weaken the immune system and damage barriers, such as the skin and mucous membranes, that help ...

Adding Opdivo (nivolumab) and Yervoy (ipilimumab) to chemotherapy did not improve how long patients with HER2-negative ...

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial While the ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our ...